272 related articles for article (PubMed ID: 28378759)
1. Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues.
Gao Y; Wang X; Sang Z; Li Z; Liu F; Mao J; Yan D; Zhao Y; Wang H; Li P; Ying X; Zhang X; He K; Wang H
Sci Rep; 2017 Apr; 7():45913. PubMed ID: 28378759
[TBL] [Abstract][Full Text] [Related]
2. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
3. Identification of Protein Abundance Changes in Hepatocellular Carcinoma Tissues Using PCT-SWATH.
Zhu Y; Zhu J; Lu C; Zhang Q; Xie W; Sun P; Dong X; Yue L; Sun Y; Yi X; Zhu T; Ruan G; Aebersold R; Huang S; Guo T
Proteomics Clin Appl; 2019 Jan; 13(1):e1700179. PubMed ID: 30365225
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
[TBL] [Abstract][Full Text] [Related]
5. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
[TBL] [Abstract][Full Text] [Related]
6. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
[TBL] [Abstract][Full Text] [Related]
7. Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction.
Long X; Zhang J; Zhang Y; Yao J; Cai Z; Yang P
Mol Biosyst; 2011 May; 7(5):1728-41. PubMed ID: 21423987
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive kinomic study via a chemical proteomic approach reveals kinome reprogramming in hepatocellular carcinoma tissues.
Wang S; Wang X; Yang X; Liu F; Li J; Li W; Bai Z; Wang H; Mao J; Li T; He K; Wang H
Proteomics; 2022 Feb; 22(4):e2100141. PubMed ID: 34932872
[TBL] [Abstract][Full Text] [Related]
11. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
[TBL] [Abstract][Full Text] [Related]
12. Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma.
Zhang D; Lim SG; Koay ES
Int J Oncol; 2007 Sep; 31(3):577-84. PubMed ID: 17671684
[TBL] [Abstract][Full Text] [Related]
13. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.
Yu Y; Shen H; Yu H; Zhong F; Zhang Y; Zhang C; Zhao J; Li H; Chen J; Liu Y; Yang P
Mol Biosyst; 2011 Jun; 7(6):1908-16. PubMed ID: 21468425
[TBL] [Abstract][Full Text] [Related]
14. Differential proteomic analysis of hepatocellular carcinoma.
Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics.
Bi X; Jin Y; Gao X; Liu F; Gao D; Jiang Y; Liu H
Eur J Mass Spectrom (Chichester); 2013; 19(2):111-21. PubMed ID: 24261083
[TBL] [Abstract][Full Text] [Related]
16. Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma.
Taoka M; Morofuji N; Yamauchi Y; Ojima H; Kubota D; Terukina G; Nobe Y; Nakayama H; Takahashi N; Kosuge T; Isobe T; Kondo T
J Proteome Res; 2014 Nov; 13(11):4847-58. PubMed ID: 24967658
[TBL] [Abstract][Full Text] [Related]
17. Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of phosphopeptides discovered in a large-scale phosphoproteome analysis of hepatocellular carcinoma.
Lin YT; Chien KY; Wu CC; Chang WY; Chu LJ; Chen MC; Yeh CT; Yu JS
J Proteomics; 2017 Mar; 157():40-51. PubMed ID: 28192239
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R
J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma.
Naboulsi W; Megger DA; Bracht T; Kohl M; Turewicz M; Eisenacher M; Voss DM; Schlaak JF; Hoffmann AC; Weber F; Baba HA; Meyer HE; Sitek B
J Proteome Res; 2016 Jan; 15(1):38-47. PubMed ID: 26626371
[TBL] [Abstract][Full Text] [Related]
20. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
